A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Condition(s):Warm Antibody Autoimmune Hemolytic AnemiaLast Updated:March 17, 2022Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Warm Antibody Autoimmune Hemolytic AnemiaLast Updated:March 17, 2022Enrolling by invitation
Condition(s):Warm Antibody Autoimmune Hemolytic AnemiaLast Updated:July 21, 2021Completed
Condition(s):Warm Antibody Autoimmune Hemolytic AnemiaLast Updated:July 11, 2023Active, not recruiting
Condition(s):Warm Antibody Autoimmune Hemolytic AnemiaLast Updated:May 25, 2023Completed
Condition(s):Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Hemolysis; Hematologic Diseases; Autoimmune Diseases; Immune System Diseases; Pathologic ProcessesLast Updated:April 19, 2012Unknown status
Condition(s):Autoimmune Hemolytic Anemia; Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Warm Antibody Autoimmune Hemolytic AnemiaLast Updated:January 30, 2024Active, not recruiting
Condition(s):Anemia, Hemolytic, AutoimmuneLast Updated:September 10, 2013Completed
Condition(s):Autoimmune Hemolytic Anemia; Autoimmune Hemolytic Anemia and Autoimmune ThrombocytopeniaLast Updated:October 13, 2021Unknown status
Condition(s):Warm Autoimmune Hemolytic AnemiaLast Updated:March 20, 2024Recruiting
Condition(s):Warm Autoimmune Hemolytic AnemiaLast Updated:June 28, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.